| Peter Zippelius |
Director |
$161,451,956 |
|
|
27 Oct 2022 |
| John R. Chiminski |
Executive Chair, Director |
$8,547,236 |
|
|
24 Aug 2022 |
| Steven L. Fasman |
EVP & Chief Admin Officer |
$2,691,088 |
|
|
23 Aug 2023 |
| Jonathan Arnold |
SVP, CCO & Div. Head BioP Del. |
$2,078,213 |
|
|
23 Aug 2023 |
| Ricardo Pravda |
Chief Transformation Officer |
$1,097,628 |
|
|
23 Aug 2023 |
| Madhavan Balachandran |
Director |
$1,020,256 |
|
|
27 Oct 2023 |
| Christa Kreuzburg |
Director |
$921,646 |
|
|
25 Jan 2024 |
| Karen Flynn |
Director |
$904,924 |
|
|
27 Oct 2023 |
| Rosemary A. Crane |
Director |
$887,598 |
|
|
27 Oct 2023 |
| Michael J. Grippo |
SVP, Strategy & Corp. Dev. |
$882,096 |
|
|
23 Aug 2023 |
| Thomas P. Castellano |
SVP, Chief Financial Officer |
$747,281 |
|
|
24 Aug 2022 |
| Kay A. Schmidt |
SVP, Enterprise Functions |
$646,486 |
|
|
24 Aug 2022 |
| Manja Boerman |
Pres. BioModalities Division |
$535,913 |
|
|
01 May 2023 |
| Patricia Hunt |
Pres. Consumer Health Div |
$418,907 |
|
|
16 Oct 2023 |
| Charles Lickfold |
Svp, Cio |
$404,965 |
|
|
23 Aug 2023 |
| Lorenzo Carletti |
SVP Global Ops Ph & Cons Hlth |
$316,216 |
|
|
23 Aug 2023 |
| Thomas W. Hawkeswood |
Pres. Pharma Prod Delivery Div |
$275,578 |
|
|
23 Aug 2023 |
| Michael A. Riley |
Pres. Bio Product Delivery Div |
$245,091 |
|
|
26 Aug 2022 |
| Ricardo Zayas |
SVP, Operations, Biologics NA |
$231,371 |
|
|
01 Aug 2023 |
| Mario Gargiulo |
SVP, Ops, Biologics Europe |
$211,034 |
|
|
01 May 2023 |
| Karen Murphy Santiago |
VP & Chief Accounting Officer |
$177,088 |
|
|
01 Aug 2023 |
| Ricci S. Whitlow |
President, CSS |
$108,677 |
|
|
21 Jan 2022 |
| Aristippos Gennadios |
Group Pres. Pharma & Consumer |
$0 |
|
|
18 Dec 2024 |
| Michael Hatzfeld |
Chief Accounting Officer |
$0 |
|
|
18 Dec 2024 |
| Steven Barg |
Director |
$0 |
|
|
18 Dec 2024 |
| JACK L. STAHL |
Director |
$0 |
|
|
18 Dec 2024 |
| ROLF A. CLASSON |
Director |
$0 |
|
|
18 Dec 2024 |
| GREGORY T. LUCIER |
Director |
$0 |
|
|
18 Dec 2024 |
| DONALD E. MOREL JR |
Director |
$0 |
|
|
18 Dec 2024 |
| JOHN J. GREISCH |
Executive Chair, Director |
$0 |
|
|
18 Dec 2024 |
| Ricky Hopson |
Pres. BioProduct Delivery, CoS |
$0 |
|
|
18 Dec 2024 |
| J. MARTIN CARROLL |
Director |
$0 |
|
|
18 Dec 2024 |
| Michael J. Barber |
Director |
$0 |
|
|
18 Dec 2024 |
| Michelle R. Ryan |
Director |
$0 |
|
|
18 Dec 2024 |
| David McErlane |
Group President, Biologics |
$0 |
|
|
18 Dec 2024 |
| Scott Gunther |
SVP, Quality & Reg. Affairs |
$0 |
|
|
18 Dec 2024 |
| Stephanie Okey |
Director |
$0 |
|
|
18 Dec 2024 |
| FRANK A. DAMELIO |
Director |
$0 |
|
|
18 Dec 2024 |
| Matti Masanovich |
SVP, Chief Financial Officer |
$0 |
|
|
18 Dec 2024 |
| Joseph Anthony Ferraro |
SVP, General Counsel, CCO |
$0 |
|
|
18 Dec 2024 |
| Alessandro Maselli |
President & CEO, Director |
$0 |
|
|
18 Dec 2024 |
| Lisa Evoli |
SVP, Chief HR Officer |
$0 |
|
|
18 Dec 2024 |